Symlin for adults with type 1 and type 2 diabetes.
Laustsen
Gary
G
D000328:Adult; D000682:Amyloid / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001066:Appetite / Q000187:drug effects; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D004334:Drug Administration Schedule; D005746:Gastric Emptying / Q000187:drug effects; D005934:Glucagon / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D058228:Islet Amyloid Polypeptide; D008657:Metabolic Clearance Rate; D009722:Nurse Practitioners / Q000458:organization & administration; D024802:Nurse's Role; D010353:Patient Education as Topic / Q000458:organization & administration; D018579:Patient Selection
D000682:Amyloid; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide; D005934:Glucagon; C105254:pramlintide